SCHEMBL6699101

SCHEMBL6699101

S=C=Nc1ccc(Sc2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ MIF P14174 1/20 0.46
▸ EHMT2 Q96KQ7 1/20 0.41
▸ EHMT1 Q9H9B1 1/20 0.41
▸ APOBEC3G Q9HC16 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ P2RY6 Q15077 1/20 0.38
▸ GRM5 P41594 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ APLNR P35414 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11708734 0.77 MIF (0.46) L3MBTL1MIFALDH1A1HPGDHSD17B10
SCHEMBL5954570 0.77 MIF (0.64) MIFALDH1A1MAPTHPGDHSD17B10
SCHEMBL484042 0.76 MIF (0.54) MIFALDH1A1MAPTUSP2HPGD
SCHEMBL2225278 0.74 L3MBTL1 (0.70) L3MBTL1EHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL30634505 0.74 L3MBTL1 (0.70) L3MBTL1EHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL9633862 0.74 ALDH1A1 (0.47) L3MBTL1MIFEHMT2EHMT1APOBEC3G
SCHEMBL6211797 0.74 DDAH1 (0.54) MIFALDH1A1MEN1MAPTKMT2A
SCHEMBL4682214 0.73 L3MBTL1 (0.96) L3MBTL1EHMT2EHMT1APOBEC3GALDH1A1
SCHEMBL11711212 0.73 L3MBTL1 (0.42) L3MBTL1MIFALDH1A1MEN1MAPT
SCHEMBL11711554 0.72 HAO1 (0.41) MIFALDH1A1MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use PFIZER, INC. 2004-09-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use MKI67, TK1, CDK2 L3MBTL1 3002/4885MIF 962/4885EHMT2 2305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback